Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0-45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocol.

Autor: Toksvang, Linea Natalie¹ (AUTHOR) Linea.natalie.toksvang@regionh.dk, Als-Nielsen, Bodil¹ (AUTHOR), Bacon, Christopher² (AUTHOR), Bertasiute, Ruta³ (AUTHOR), Duarte, Ximo⁴ (AUTHOR), Escherich, Gabriele⁵ (AUTHOR), Helgadottir, Elín Anna⁶ (AUTHOR), Johannsdottir, Inga Rinvoll⁷ (AUTHOR), Jónsson, Ólafur G.⁶ (AUTHOR), Kozlowski, Piotr⁸ (AUTHOR), Langenskjöld, Cecilia⁹ (AUTHOR), Lepik, Kristi¹⁰ (AUTHOR), Niinimäki, Riitta¹¹ (AUTHOR), Overgaard, Ulrik Malthe¹² (AUTHOR), Punab, Mari¹³ (AUTHOR), Räty, Riikka¹⁴ (AUTHOR), Segers, Heidi¹⁵ (AUTHOR), van der Sluis, Inge¹⁶ (AUTHOR), Smith, Owen Patrick¹⁷ (AUTHOR), Strullu, Marion¹⁸ (AUTHOR)

Publikováno v: BMC Cancer. 5/2/2022, Vol. 22 Issue 1, p1-19. 19p.

Prevalence of non‐adherence and non‐compliance during maintenance therapy in adults with acute lymphoblastic leukemia and their associations with survival.

Autor: Kristjánsdóttir, Elsa Rán^1,2 (AUTHOR), Toksvang, Linea Natalie^1,2 (AUTHOR), Schmiegelow, Kjeld^1,2,3 (AUTHOR), Rank, Cecilie Utke^1,4 (AUTHOR) cecilie.utke.rank@regionh.dk

Publikováno v: European Journal of Haematology. Feb2022, Vol. 108 Issue 2, p109-117. 9p.

Additional file 3 of Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0–45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocol

Autor: Toksvang, Linea Natalie, Als-Nielsen, Bodil, Bacon, Christopher, Bertasiute, Ruta, Duarte, Ximo, Escherich, Gabriele, Helgadottir, Elín Anna, Johannsdottir, Inga Rinvoll, Jónsson, Ólafur G., Kozlowski, Piotr, Langenskjöld, Cecilia, Lepik, Kristi, Niinimäki, Riitta, Overgaard, Ulrik Malthe, Punab, Mari, Räty, Riikka, Segers, Heidi, van der Sluis, Inge, Smith, Owen Patrick, Strullu, Marion, Vaitkevičienė, Goda, Wik, Hilde Skuterud, Heyman, Mats, Schmiegelow, Kjeld

Additional file 3. Potential Hy's Law cases.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66d24faf56bc9bd5a2cfbfb2c588b041

Additional file 6 of Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0–45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocol

Autor: Toksvang, Linea Natalie, Als-Nielsen, Bodil, Bacon, Christopher, Bertasiute, Ruta, Duarte, Ximo, Escherich, Gabriele, Helgadottir, Elín Anna, Johannsdottir, Inga Rinvoll, Jónsson, Ólafur G., Kozlowski, Piotr, Langenskjöld, Cecilia, Lepik, Kristi, Niinimäki, Riitta, Overgaard, Ulrik Malthe, Punab, Mari, Räty, Riikka, Segers, Heidi, van der Sluis, Inge, Smith, Owen Patrick, Strullu, Marion, Vaitkevičienė, Goda, Wik, Hilde Skuterud, Heyman, Mats, Schmiegelow, Kjeld

Additional file 6. Supplementary Table 1.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0d778697a3de460140c1c0b4f6c1d77

Additional file 4 of Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0–45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocol

Autor: Toksvang, Linea Natalie, Als-Nielsen, Bodil, Bacon, Christopher, Bertasiute, Ruta, Duarte, Ximo, Escherich, Gabriele, Helgadottir, Elín Anna, Johannsdottir, Inga Rinvoll, Jónsson, Ólafur G., Kozlowski, Piotr, Langenskjöld, Cecilia, Lepik, Kristi, Niinimäki, Riitta, Overgaard, Ulrik Malthe, Punab, Mari, Räty, Riikka, Segers, Heidi, van der Sluis, Inge, Smith, Owen Patrick, Strullu, Marion, Vaitkevičienė, Goda, Wik, Hilde Skuterud, Heyman, Mats, Schmiegelow, Kjeld

Additional file 4. Study information sheet.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03407ce1650adc3d87c4ca1b3d86b377